MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2017 International Congress

    Short term effects of bilateral STN DBS on psychiatric profile in Parkinson’s disease

    R. Alugolu, M.B. Kesani, B. Ganji, V. Mudumba, R. Mrudula, R. Borgohain, P. Gaddamanugu (Hyderabad, India)

    Objective: We intend to look into the effects of bilateral STN DBS on Psychiatric profile of Parkinson’s patients. Background: Parkinson’s disease is a well-known degenerative…
  • 2017 International Congress

    Absence of depression in de novo Parkinson’s disease: a benign motor phenotype?

    H.S. YOO, Y. Lee, J.J. Lee, S.J. Chung, P.H. Lee, Y.H. Sohn (Seoul, Republic of Korea)

    Objective: This study aimed to assess the impact of early depression on motor deficits relative to the level of striatal dopaminergic depletion in patients with…
  • 2017 International Congress

    Improving Diagnosis and Treatment of Anxiety in Parkinson’s Disease: IDATA-PD Study

    N. Dissanayaka, N. Pachana, J. O'Sullivan, R. Marsh, P. Silburn, E. White, E. Torbey, D. Pye, L. Mitchell, J.H. Yang, T. Au, G. Mellick, D. Copland, A. Toft, G. Byrne (Brisbane, Australia)

    Objective: We investigated PD-specific features of anxiety for clear conceptualisation, and assessed targeted psychotherapy for anxiety in Parkinson’s disease (PD). Background: Anxiety is poorly diagnosed in PD…
  • 2017 International Congress

    Treatment of Psychosis in Parkinson’s Disease: Evidence-Based Recommendations Versus Actual Clinical Practice

    L.G. Chan, A. Kong, L. Tan (Singapore, Singapore)

    Objective: To examine if actual clinical practice of antipsychotic use in Parkinson's Disease patients are consistent with published evidence-based reviews of treatment recommendations and discuss…
  • 2017 International Congress

    Electrophysiological markers for emotional and cognitive impairment in Parkinson’s disease

    N. Dissanayaka, T. Au, A. Angwin, J. O'Sullivan, G. Byrne, P. Silburn, R. Marsh, G. Mellick, D. Copland (Brisbane, Australia)

    Objective: This study aims to identify markers for emotional and cognitive dysfunctions in Parkinson’s disease (PD) using non-invasive electroencephalography (EEG). This study investigates event related…
  • 2017 International Congress

    The role of habenula and amygdala dysfunction in Parkinson’s disease patients with punding

    V. Markovic, F. Agosta, E. Canu, A. Inuggi, I. Petrovic, I. Stankovic, F. Imperiale, T. Stojkovic, V. Kostic, M. Filippi (Belgrade, Serbia)

    Objective: To assess whether a functional dysregulation of the habenula and amygdala, as modulators of the reward brain circuit, contributes to Parkinson’s disease (PD)-punding. Background:…
  • 2017 International Congress

    Minor hallucinations in Parkinson’s disease: neuropshycological and neurophysiological correlates in a representative sample of non-demented patients.

    J. Pagonabarraga, J. Marin-Lahoz, A. Horta, H. Bejr-Kasem, M. Cornella, J. Pérez-Pérez, S. Martinez-Horta, J. Kulisevsky (Barcelona, Spain)

    Objective: To study the neuropsychological and neurophysiological correlates of minor hallucinations (mH) in non-demented PD patients, by using different scales and the event-related potentials (ERP)…
  • 2017 International Congress

    What do patients with Parkinson’s disease see in their hallucinations? Classification of hallucinations which are seen in Parkinson’s Disease; Single Center Experience

    A. Acarer, S. Ciftci, Z. Colakoglu (Izmir, Turkey)

    Objective: Our purpose is to evaluate  and classify visiual hallucination of  52 patients with Parkinson' s Disease  and to detect if there is any relation between…
  • 2017 International Congress

    Impulse Control Disorders in Parkinson’s Disease: Prevalence and Clinical Features in the Rush University Movement Disorders Clinic

    M. Rossi, G. Stebbins, B. Barton (Chicago, IL, USA)

    Objective: Investigate the prevalence and characteristics of Impulse Control Disorders (ICDs) in the PD population as compared to non-ICD patients in the Rush University Movement Disorders (RUMD) database.…
  • 2017 International Congress

    Delusional Misidentification Syndrome for “Self” in two patients with Parkinson`s Disease.

    S. Ray, D. Park, D. Burdick, A. Griffith, J. Shaw, P. Agarwal (Kirkland, WA, USA)

    Objective:  We report two patients with Parkinson’s disease(PD) and Capgras syndrome (CS) with confusion of identify not just of close acquaintances but also of “self”.…
  • « Previous Page
  • 1
  • …
  • 1298
  • 1299
  • 1300
  • 1301
  • 1302
  • …
  • 1554
  • Next Page »

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • An atypical and interesting feature of Parkinson´s disease
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • Patients with Essential Tremor Live Longer than their Relatives
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley